72.65USD+0.76%Mkt Cap: 27.95B USDP/E: 31.09Last update: 2026-05-26
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States an…
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap27.95B USD
Enterprise Value26.71B USD
Revenue (TTM)4.82B USD
Gross Profit2.80B USD
Net Income (TTM)836.30M USD
Revenue/Share12.39 USD
Last Price72.65 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees11.0K
CountryUS
SectorHealthcare
IndustryMedical Devices
ISINUS2521311074
Valuation
P/E (Trailing)31.09
P/E (Forward)23.57
PEG1.33
EV/EBITDA20.67
EV/Revenue5.54
P/S5.76
P/B9.38
EPS (TTM)2.33
EPS (Forward)3.05
52W Range
54.1152% of range89.98
52W High89.98 USD
52W Low54.11 USD
Profitability
Gross Margin60.10%
Oper. Margin21.42%
EBITDA Margin26.82%
Profit Margin17.94%
ROE30.46%
ROA13.19%
Growth
Revenue Growth15.00%
Earnings Growth92.20%
Cash Flow & Leverage
Operating CF1.44B USD
CapEx (TTM)363.50M USD
FCF Margin21.93%
FCF Yield3.78%
Net Debt-1.03B USD
Net Debt/EBITDA-0.80
Balance Sheet
Debt/Equity0.51
Current Ratio1.95
Quick Ratio1.58
Book Value/Sh7.662 USD
Cash/Share6.259 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split4:1
Split DateJun 13, 2022
Analyst Consensus
Rating1.4 (Strong Buy)
Target (Mean)81.64 USD
Target Range64.00 USD – 112.00 USD
# Analysts25
Ownership
Shares Out.385.87M
Float384.08M
Insiders0.28%
Institutions102.69%
Short Interest
Short Ratio4.3d
Short % Float5.46%
Short % Out.4.75%
Shares Short18.32M
Short (prev mo.)14.72M
Technical
SMA 5063.32 (+14.7%)
SMA 20067.98 (+6.9%)
Beta1.40
S&P 52W Chg28.31%
Avg Vol (30d)6.26M
Avg Vol (10d)8.32M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—